278 related articles for article (PubMed ID: 26861490)
1. Aleglitazar, a Balanced Dual PPARα and -γ Agonist, Protects the Heart Against Ischemia-Reperfusion Injury.
Qian J; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y
Cardiovasc Drugs Ther; 2016 Apr; 30(2):129-41. PubMed ID: 26861490
[TBL] [Abstract][Full Text] [Related]
2. Aleglitazar, a dual peroxisome proliferator-activated receptor-α and -γ agonist, protects cardiomyocytes against the adverse effects of hyperglycaemia.
Chen Y; Chen H; Birnbaum Y; Nanhwan MK; Bajaj M; Ye Y; Qian J
Diab Vasc Dis Res; 2017 Mar; 14(2):152-162. PubMed ID: 28111985
[TBL] [Abstract][Full Text] [Related]
3. The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.
Werner CM; Schirmer SH; Gensch C; Pavlickova V; Pöss J; Wright MB; Böhm M; Laufs U
Br J Pharmacol; 2014 May; 171(10):2685-703. PubMed ID: 24467636
[TBL] [Abstract][Full Text] [Related]
4. Dual PPARα/γ agonist aleglitazar confers stroke protection in a model of mild focal brain ischemia in mice.
Boujon V; Uhlemann R; Wegner S; Wright MB; Laufs U; Endres M; Kronenberg G; Gertz K
J Mol Med (Berl); 2019 Aug; 97(8):1127-1138. PubMed ID: 31147725
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of the dual peroxisome proliferator activated receptor (PPAR)α/γ agonist aleglitazar in attenuating TNF-α-mediated inflammation and insulin resistance in human adipocytes.
Massaro M; Scoditti E; Pellegrino M; Carluccio MA; Calabriso N; Wabitsch M; Storelli C; Wright M; De Caterina R
Pharmacol Res; 2016 May; 107():125-136. PubMed ID: 26976796
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
Birnbaum Y; Long B; Qian J; Perez-Polo JR; Ye Y
Basic Res Cardiol; 2011 May; 106(3):431-46. PubMed ID: 21360043
[TBL] [Abstract][Full Text] [Related]
7. GYY4137 protects against myocardial ischemia/reperfusion injury via activation of the PHLPP-1/Akt/Nrf2 signaling pathway in diabetic mice.
Qiu Y; Wu Y; Meng M; Luo M; Zhao H; Sun H; Gao S
J Surg Res; 2018 May; 225():29-39. PubMed ID: 29605032
[TBL] [Abstract][Full Text] [Related]
8. Methylophiopogonanone A suppresses ischemia/reperfusion-induced myocardial apoptosis in mice via activating PI3K/Akt/eNOS signaling pathway.
He F; Xu BL; Chen C; Jia HJ; Wu JX; Wang XC; Sheng JL; Huang L; Cheng J
Acta Pharmacol Sin; 2016 Jun; 37(6):763-71. PubMed ID: 27063216
[TBL] [Abstract][Full Text] [Related]
9. Cilostazol protects mice against myocardium ischemic/reperfusion injury by activating a PPARγ/JAK2/STAT3 pathway.
Li J; Xiang X; Gong X; Shi Y; Yang J; Xu Z
Biomed Pharmacother; 2017 Oct; 94():995-1001. PubMed ID: 28810537
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
[TBL] [Abstract][Full Text] [Related]
11. Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats.
Ren-an Q; Juan L; Chuyuan L; Wenjuan F; Chunyan H; Xuemei Y; Lin H; Hong N
J Ethnopharmacol; 2014 Oct; 156():190-8. PubMed ID: 25178948
[TBL] [Abstract][Full Text] [Related]
12. Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway.
Tang L; Mo Y; Li Y; Zhong Y; He S; Zhang Y; Tang Y; Fu S; Wang X; Chen A
Biochem Biophys Res Commun; 2017 May; 486(3):774-780. PubMed ID: 28343995
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effects of the Peroxisome Proliferator-Activated Receptor α/γ Agonist Aleglitazar on Progressive Hepatic and Splanchnic Abnormalities in Cirrhotic Rats with Portal Hypertension.
Tsai HC; Li TH; Huang CC; Huang SF; Liu RS; Yang YY; Hsieh YC; Lee KC; Huang YH; Hou MC; Lin HC
Am J Pathol; 2018 Jul; 188(7):1608-1624. PubMed ID: 29929914
[TBL] [Abstract][Full Text] [Related]
14. Protective Effect of Peroxisome Proliferator-Activated Receptor α Activation against Cardiac Ischemia-Reperfusion Injury Is Related to Upregulation of Uncoupling Protein-3.
Song JW; Kim HJ; Lee H; Kim JW; Kwak YL
Oxid Med Cell Longev; 2016; 2016():3539649. PubMed ID: 26770648
[TBL] [Abstract][Full Text] [Related]
15. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
16. Aleglitazar, a dual PPARα and PPARγ agonist for the potential oral treatment of type 2 diabetes mellitus.
Lecka-Czernik B
IDrugs; 2010 Nov; 13(11):793-801. PubMed ID: 21046527
[TBL] [Abstract][Full Text] [Related]
17. Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice.
Koka S; Das A; Salloum FN; Kukreja RC
Free Radic Biol Med; 2013 Jul; 60():80-8. PubMed ID: 23385031
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress.
Tao L; Gao E; Jiao X; Yuan Y; Li S; Christopher TA; Lopez BL; Koch W; Chan L; Goldstein BJ; Ma XL
Circulation; 2007 Mar; 115(11):1408-16. PubMed ID: 17339545
[TBL] [Abstract][Full Text] [Related]
19. Resolvin E1 protects the rat heart against reperfusion injury.
Keyes KT; Ye Y; Lin Y; Zhang C; Perez-Polo JR; Gjorstrup P; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H153-64. PubMed ID: 20435846
[TBL] [Abstract][Full Text] [Related]
20. Chrysin rescues rat myocardium from ischemia-reperfusion injury via PPAR-γ/Nrf2 activation.
Rani N; Arya DS
Eur J Pharmacol; 2020 Sep; 883():173389. PubMed ID: 32707190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
